Patients with Normal Intestinal Absorption: Where the oral route is not deemed adequate, initial treatment similar to that for patients with pernicious anemia may be indicated depending on the severity of the deficiency
Since Retatrutide is still under investigation, it is not currently licensed for general medical use
Since several studies document a decrease in adherence as therapeutic complexity increases, an improvement in therapeutic adherence can be expected with the use of this drug, especially considering the excellent results that patients can achieve in terms of weight reduction
The 10mg dose produced 19.5% average weight loss
Be Cognizant of Hormonal Factors Family Planning, Pregnancy, and Breastfeeding Studies have shown that a womans risk of developing certain gynecologic cancers is influenced by reproductive factors, such as oral contraceptive use, pregnancy, and breastfeeding, all of which affect exposure to estrogen and progesterone, hormones produced by the ovaries
